Comparative efficacy and safety of combination therapies for advanced melanoma: a network meta-analysis

Comparative efficacy and safety of combination therapies for advanced melanoma: a network meta-analysis

Abstract Background Currently, the major treatment modalities of advanced melanoma are immune check point and mitogen-activated protein kinase (MAPK) pathway inhibitors. As lacking head-to-head randomizedcontrolled trials (RCTs) comparing immune check point and MAPK pathway inhibitors, we evaluated...

Full description

Bibliographic Details
Main Authors: Qing An, Zhihao Liu
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Cancer
Subjects:
Advanced melanoma
PD-1/L1 blockade
CTLA-4 blockade
BRAF inhibitor
MEK inhibitor
Online Access:http://link.springer.com/article/10.1186/s12885-018-5259-8

Internet

http://link.springer.com/article/10.1186/s12885-018-5259-8

Similar Items